Sign In
21 May 2014 11:45
ο»Ώ
Β
Β
Instem plc
("Instem" or the "Company")
Β
Result of Annual General Meeting
Β
Instem (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that at the Annual General Meeting held on Tuesday 20th May, all resolutions were duly passed.
Β
For further information, please contact:
Instem plc | www.instem.com |
Phil Reason, CEO | Tel: +44 (0) 1785 825 600 |
Nigel Goldsmith, CFO | Β |
Β | Β |
N+1 Singer (Nominated Adviser & Broker) | Tel: +44 (0) 20 7496 3000 |
Richard Lindley | Β |
Nick Owen | Β |
Β | Β |
Walbrook PR Ltd | Tel: +44 (0) 20 7933 8780 or instem@walbrookpr.com |
Bob Huxford | Mob: +44 (0)7747 635 908 |
Helen Cresswell | Mob: +44 (0)7841 917 679 |
Β
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutionsfor data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidlyΒ expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Β
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledgethrough the extraction and harmonisation of actionable scientific information.
Β
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Β
To learn more about Instem solutions and its mission, please visit www.instem.com.
Β
Β
Follow the stocks
